why Kindly MD Inc [NAKA] is a Good Choice for Investors After New Price Target of $8.00

Brandon Evans

Kindly MD Inc [NASDAQ: NAKA] jumped around 0.03 points on Friday, while shares priced at $1.13 at the close of the session, up 2.73%.

Kindly MD Inc stock is now 6.61% up from its year-to-date (YTD) trading value. NAKA Stock saw the intraday high of $1.145 and lowest of $1.0802 per share. The company’s 52-week high price is 34.77, which means current price is +6.60% above from all time high which was touched on 05/22/25.

Compared to the average trading volume of 9.60M shares, NAKA reached a trading volume of 29765331 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about Kindly MD Inc [NAKA]?

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for NAKA shares is $8.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on NAKA stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Maxim Group have made an estimate for Kindly MD Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on September 03, 2025.

The Price to Book ratio for the last quarter was 0.95, with the Price to Cash per share for the same quarter was set at 0.01.

How has NAKA stock performed recently?

Kindly MD Inc [NAKA] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -1.74. With this latest performance, NAKA shares dropped by -65.55% in over the last four-week period, additionally sinking by -27.56% over the last 6 months – not to mention a drop of -8.87% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for NAKA stock in for the last two-week period is set at 34.34, with the RSI for the last a single of trading hit 0.4455, and the three-weeks RSI is set at 0.9756 for Kindly MD Inc [NAKA]. The present Moving Average for the last 50 days of trading for this stock 6.1189, while it was recorded at 1.1200 for the last single week of trading, and 6.2094 for the last 200 days.

Kindly MD Inc [NAKA]: Deeper insight into the fundamentals

Operating Margin for any stock indicates how profitable investing would be, and Kindly MD Inc [NAKA] shares currently have an operating margin of -245.80% and a Gross Margin at -108.15%. Kindly MD Inc’s Net Margin is presently recorded at -244.09%.

Kindly MD Inc (NAKA) Capital Structure & Debt Analysis

According to recent financial data for Kindly MD Inc. ( NAKA), the Return on Equity (ROE) stands at -81.92%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -71.25%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Kindly MD Inc’s Return on Invested Capital (ROIC) is -58.17%, showcasing its effectiveness in deploying capital for earnings.

Kindly MD Inc (NAKA) Efficiency & Liquidity Metrics

Based on Kindly MD Inc’s (NAKA) latest financial statements, the Debt-to-Equity Ratio is 0.06%, indicating its reliance on debt financing relative to shareholder equity.

Kindly MD Inc (NAKA) Efficiency & Liquidity Metrics

From an operational efficiency perspective, Kindly MD Inc. (NAKA) effectively leverages its workforce, generating an average of -$89672.13 per employee. The company’s liquidity position is robust, with a Current Ratio of 12.99% and a Quick Ratio of 12.99%, indicating strong ability to cover short-term liabilities.

Insider trade positions for Kindly MD Inc [NAKA]

There are presently around $0.21%, or 0.22%% of NAKA stock, in the hands of institutional investors.

DBT News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.